Related Experiment Video
Updated: Apr 4, 2026

Hydrodynamic Renal Pelvis Injection for Non-viral Expression of Proteins in the Kidney
Published on: January 8, 2018
Burden of Injection Drug Use-Related Infection Hospitalizations in Tennessee, 2016-2023
Emily R Moore1, Anastasia N Cajigal2, Amber J Coyne2
1Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Background:
Injection drug use-related infections cause substantial morbidity and can be mitigated by harm reduction programs. The objective was to describe Tennessee's injection-related infection hospitalization burden to guide syringe service program expansion efforts.
Method:
Injection-related infection hospitalizations were retrospectively evaluated from 2016 to 2023 using the Tennessee Hospital Discharge Data System. Injection-related infection criteria were met if discharge International Classification of Diseases, 10th Revision (ICD-10) codes indicated both drug use and an infection that could be introduced through injection. Hospitalization characteristics, including demographics (age, sex, race/ethnicity, county), charges, and main payor, were described using counts (%) and median (interquartile range [IQR]). Incidence was calculated using US Census Bureau midyear estimates.
Results:
During 2016-2023, injection-related infections comprised 1.6% (n = 79 276) of 5 million hospitalizations, incurring 602 321 hospitalization days and $5.38 billion in charges. The main payor was most frequently public insurance (n = 43 448, 54.8%) and self-pay (n = 23 001, 29.0%). Bacteremia or sepsis was most often diagnosed (n = 45 105, 56.9%), followed by skin and soft tissue (n = 17 152, 21.6%), endocarditis (n = 7386, 9.3%), musculoskeletal (n = 6458, 8.1%), and other (n = 3175, 4.0%) infections. Endocarditis incurred the greatest episodic length of stay (median 8 days [IQR 4-17]) and charges (median $60 633.50 [IQR $29 238-$130 368]). The annual hospitalization rate peaked at 194.29 per 100 000 persons in 2018, plateaued, and then decreased to 186.38 per 100 000 persons in 2023. Eastern Tennessee, part of the Appalachia region, had the highest rates of injection-related infections.
Conclusions:
Injection-related infection annual hospitalization rates since 2018 have plateaued. Expanded access to syringe service programs, particularly in eastern Tennessee, can help prevent these costly hospitalizations.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Sexually Transmitted Infections

